Quick answer: the La Roche-Posay Toleriane Double Repair Face Moisturizer comes closest to the CeraVe PM Facial Moisturizing Lotion: it has every key treatment active in it (Niacinamide). On price, both sit in the Mid-range tier. It also overlaps with 4 other products below.
Products the Toleriane Double Repair Face Moisturizer matches
2 of 3
hero actives matched
Same price tierNiacinamideCeramides
Why it holds up: Matches every key treatment active in the original: Niacinamide.
Full ingredient analysis →See them side by side →1 of 2
hero actives matched
Same price tierNiacinamide
Why it holds up: Shares Niacinamide, but not the original's Retinol.
Full ingredient analysis →See them side by side →Stratia
1 of 2
hero actives matched
Same price tierCeramides
Why it holds up: Shares Ceramides, but not Squalane.
Full ingredient analysis →See them side by side →First Aid Beauty
1 of 3
hero actives matched
Same price tierCeramides
Why it holds up: Shares Ceramides, but not Colloidal Oatmeal and Shea Butter.
Full ingredient analysis →See them side by side →1 of 3
hero actives matched
Pricier originalCeramides
The catch: Only shares supporting ingredients (Ceramides). It doesn't contain the original's Peptides, so it won't do the same job.
Full ingredient analysis →See them side by side →Common questions
Is the La Roche-Posay Toleriane Double Repair Face Moisturizer a real dupe?
It shares hero actives with 5 same-category products in our catalogue, most closely the CeraVe PM Facial Moisturizing Lotion (matching 2 of 3 of its hero actives). "Dupe" here means shared key ingredients, not an identical formula.
Does matching more hero actives make it better?
No. The match count only shows how many hero actives are shared. The base, supporting ingredients, texture and price still differ, so use the side-by-side comparison for the full picture.
Go deeper
Toleriane Double Repair Face Moisturizer
Full ingredient breakdown for this product.
Open the analysis →Educational information only — not medical advice. Overlap reflects shared hero actives, not clinical equivalence.